Company intelligence / Profile preview

Intergen

Purchase, New York, USA

Ownership: Private
Development stage: Other

Overview

Intergen develops and manufactures innovative biotechnology products used in research, drug discovery, and diagnostics, particularly in cancer therapeutics, hematology, and immunology. The company supplies academic and industrial researchers worldwide and is known for its expertise in large-scale biological manufacturing to GMP standards. It primarily functions as a supplier and contract manufacturer, without a proprietary clinical-stage pipeline.

Therapeutic areas: HematologyOncologyImmunology
Modalities: Recombinant proteinProteinBiologic
Industry: Drug Discovery Services

Partnerships

Strategic marketing partners in Japan

Beyond the preview

Go deeper on Intergen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intergen.

Explore the full profile